CAMBRIDGE, Mass., Feb. 28, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the Cowen and Company 31st Annual Health Care Conference on Monday, March 7, 2011 at 4:00 p.m. ET in Boston.
In addition, Infinity will be presenting at the Barclays Capital 2011 Global Healthcare Conference in Miami on Wednesday, March 16, 2011 at 8:30 a.m. ET.
A live webcast of both Infinity presentations will be accessible on the "investors/media" section of the company's website, , and will be available for 30 days following the event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs in the inhibition of the Hedgehog pathway, the Hsp90 chaperone system, fatty acid amide hydrolase, and phosphoinositide-3-kinase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at www.infi.com.
CONTACT: Infinity Pharmaceuticals, Inc. Jaren Irene Madden, 617-453-1336 Jaren.Madden@infi.com http://www.infi.com
